| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | CFO AND COO | Mar 14, 2024 | Option Exercise | $0.90 | 2,591 | 2,332 | 35,976 | Mar 15, 2024, 05:40 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Mar 14, 2024 | Option Exercise | $0.90 | 8,727 | 7,854 | 74,792 | Mar 15, 2024, 05:36 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | CFO AND COO | Feb 07, 2024 | Option Exercise | $0.67 | 2,443 | 1,637 | 29,901 | Feb 09, 2024, 05:38 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Feb 07, 2024 | Option Exercise | $0.67 | 9,212 | 6,172 | 60,408 | Feb 09, 2024, 05:36 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | CFO AND COO | Aug 03, 2023 | Option Exercise | $1.02 | 1,422 | 1,450 | 25,444 | Aug 04, 2023, 04:45 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Aug 03, 2023 | Option Exercise | $1.01 | 4,744 | 4,791 | 48,300 | Aug 04, 2023, 04:42 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | CFO AND COO | Jun 12, 2023 | Option Exercise | $1.14 | 1,575 | 1,791 | 22,116 | Jun 13, 2023, 04:54 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Feb 07, 2023 | Option Exercise | $1.36 | 6,977 | 9,489 | 40,477 | Feb 08, 2023, 06:00 PM | |
| ONTX | Onconova Therapeutics, Inc. | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | Feb 07, 2023 | Option Exercise | $1.36 | 1,242 | 1,689 | 10,487 | Feb 08, 2023, 05:58 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | CFO AND COO | Feb 07, 2023 | Option Exercise | $1.36 | 1,785 | 2,428 | 18,191 | Feb 08, 2023, 05:56 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | CFO AND COO | Aug 03, 2022 | Option Exercise | $1.32 | 1,355 | 1,789 | 13,076 | Aug 04, 2022, 04:38 PM | |
| ONTX | Onconova Therapeutics, Inc. | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | Aug 03, 2022 | Option Exercise | $1.32 | 1,135 | 1,498 | 5,896 | Aug 04, 2022, 04:34 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | Aug 03, 2022 | Option Exercise | $1.32 | 4,562 | 6,022 | 26,134 | Aug 04, 2022, 04:30 PM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Jan 28, 2022 | Buy | $1.67 | 1,500 | 2,505 | 24,514 | Jan 31, 2022, 08:41 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Jan 21, 2022 | Buy | $2.02 | 1,500 | 3,030 | 23,014 | Jan 24, 2022, 08:40 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP CORP DEV & GEN COUNSEL | Jan 14, 2022 | Buy | $2.20 | 1,500 | 3,300 | 21,514 | Jan 18, 2022, 09:12 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Jan 07, 2022 | Buy | $2.39 | 1,500 | 3,585 | 20,014 | Jan 10, 2022, 08:39 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP CORP DEV & GEN COUNSEL | Nov 19, 2021 | Buy | $3.16 | 1,000 | 3,160 | 18,514 | Nov 23, 2021, 09:20 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Nov 18, 2021 | Option Exercise | $3.00 | 5,000 | 15,000 | 17,514 | Nov 19, 2021, 08:45 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Sep 28, 2021 | Buy | $4.20 | 2,381 | 10,000 | 12,515 | Sep 29, 2021, 08:27 AM | |
| ONTX | Onconova Therapeutics, Inc. | Gelder Mark S. MD | Chief Medical Officer | Sep 28, 2021 | Buy | $4.20 | 2,381 | 10,000 | 2,381 | Sep 29, 2021, 08:25 AM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | President, Chief Executive Off | Sep 28, 2021 | Buy | $4.20 | 2,381 | 10,000 | 18,130 | Sep 28, 2021, 12:34 PM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Sep 28, 2021 | Buy | $4.20 | 5,952 | 24,998 | 21,334 | Sep 28, 2021, 12:32 PM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Feb 16, 2021 | Buy | $1.00 | 12,000 | 12,000 | 152,000 | Feb 17, 2021, 08:57 AM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | Chief Financial Officer | Feb 16, 2021 | Buy | $1.00 | 15,000 | 15,000 | 145,213 | Feb 17, 2021, 08:55 AM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | President, Chief Executive Off | Feb 16, 2021 | Buy | $1.00 | 20,000 | 20,000 | 236,226 | Feb 17, 2021, 08:48 AM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Feb 16, 2021 | Buy | $1.00 | 25,000 | 25,000 | 230,716 | Feb 17, 2021, 08:46 AM | |
| ONTX | Onconova Therapeutics, Inc. | Shoemaker Mary Teresa | Director | Feb 16, 2021 | Buy | $1.00 | 13,000 | 13,000 | 50,735 | Feb 17, 2021, 08:45 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Dec 11, 2020 | Buy | $0.32 | 30,000 | 9,600 | 140,000 | Dec 14, 2020, 09:00 AM | |
| ONTX | Onconova Therapeutics, Inc. | Shoemaker Mary Teresa | Director | Nov 25, 2020 | Buy | $0.26 | 37,735 | 10,000 | 37,735 | Nov 30, 2020, 05:14 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | Chief Financial Officer | Nov 25, 2020 | Buy | $0.26 | 16,755 | 4,356 | 125,599 | Nov 30, 2020, 05:11 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | Chief Financial Officer | Nov 27, 2020 | Buy | $0.26 | 4,614 | 1,200 | 130,213 | Nov 30, 2020, 05:11 PM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | Nov 25, 2020 | Buy | $0.26 | 20,000 | 5,120 | 110,000 | Nov 30, 2020, 05:09 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | President, Chief Executive Off | Nov 25, 2020 | Buy | $0.26 | 40,000 | 10,360 | 216,226 | Nov 30, 2020, 05:08 PM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Nov 24, 2020 | Buy | $0.26 | 38,774 | 10,004 | 205,716 | Nov 27, 2020, 01:34 PM | |
| ONTX | Onconova Therapeutics, Inc. | Reddy E Premkumar | Director | Aug 27, 2020 | Sale | $0.27 | 527,863 | 143,948 | 16,683 | Aug 31, 2020, 04:49 PM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Aug 27, 2020 | Sale | $0.27 | 182,492 | 49,620 | 21,919 | Aug 31, 2020, 04:42 PM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Aug 27, 2020 | Sale | $0.27 | 1,876 | 510 | 0 | Aug 31, 2020, 04:42 PM | |
| ONTX | Onconova Therapeutics, Inc. | GROOPMAN JEROME | Director | May 19, 2020 | Buy | $0.36 | 10,000 | 3,626 | 10,001 | May 21, 2020, 05:10 PM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | May 19, 2020 | Buy | $0.37 | 15,000 | 5,550 | 90,000 | May 20, 2020, 09:19 AM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | Chief Financial Officer | May 19, 2020 | Buy | $0.36 | 21,000 | 7,560 | 108,844 | May 20, 2020, 09:09 AM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | President, Chief Executive Off | May 19, 2020 | Buy | $0.37 | 26,800 | 9,857 | 176,226 | May 20, 2020, 09:07 AM | |
| ONTX | Onconova Therapeutics, Inc. | MEHTA VIREN | Director | Nov 25, 2019 | Buy | $0.20 | 250,000 | 50,000 | 250,857 | Nov 27, 2019, 08:33 AM | |
| ONTX | Onconova Therapeutics, Inc. | Reddy E Premkumar | Director | Nov 25, 2019 | Buy | $0.20 | 500,000 | 100,000 | 544,546 | Nov 26, 2019, 07:57 AM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Nov 25, 2019 | Buy | $0.20 | 150,000 | 30,000 | 166,942 | Nov 26, 2019, 07:53 AM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | President, Chief Executive Off | Nov 25, 2019 | Buy | $0.20 | 149,000 | 29,800 | 149,426 | Nov 26, 2019, 07:51 AM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | Chief Financial Officer | Nov 25, 2019 | Buy | $0.20 | 87,500 | 17,500 | 87,844 | Nov 26, 2019, 07:50 AM | |
| ONTX | Onconova Therapeutics, Inc. | OLER ABRAHAM N. | VP Corp Dev & Gen Counsel | Nov 25, 2019 | Buy | $0.20 | 75,000 | 15,000 | 75,000 | Nov 26, 2019, 07:46 AM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Sep 25, 2019 | Buy | $1.60 | 7,260 | 11,616 | 16,942 | Sep 26, 2019, 06:22 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 24, 2019 | Sale | $1.19 | 16,700 | 19,873 | 616,389 | Sep 26, 2019, 04:16 PM | |
| ONTX | Onconova Therapeutics, Inc. | Boyd Steven | 10% Owner | Sep 23, 2019 | Sale | $1.27 | 10,249 | 13,016 | 816,702 | Sep 25, 2019, 05:41 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 20, 2019 | Sale | $1.62 | 75,119 | 121,430 | 670,331 | Sep 24, 2019, 04:08 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 23, 2019 | Sale | $1.23 | 37,242 | 45,968 | 633,089 | Sep 24, 2019, 04:08 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 18, 2019 | Sale | $2.10 | 49,995 | 105,015 | 745,450 | Sep 20, 2019, 04:05 PM | |
| ONTX | Onconova Therapeutics, Inc. | 683 Capital Partners, LP | 10% Owner | Sep 18, 2019 | Sale | $2.03 | 506,877 | 1,030,684 | 848,151 | Sep 20, 2019, 03:21 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 11, 2019 | Sale | $2.75 | 1,247 | 3,432 | 795,445 | Sep 13, 2019, 04:24 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 09, 2019 | Sale | $2.77 | 400 | 1,106 | 796,692 | Sep 11, 2019, 04:16 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 06, 2019 | Sale | $2.78 | 5,015 | 13,954 | 797,092 | Sep 09, 2019, 04:10 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Sep 05, 2019 | Sale | $2.75 | 400 | 1,100 | 802,107 | Sep 09, 2019, 04:10 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Jul 09, 2019 | Sale | $2.84 | 8,185 | 23,204 | 805,249 | Jul 11, 2019, 04:43 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Jul 10, 2019 | Sale | $2.81 | 2,742 | 7,697 | 802,507 | Jul 11, 2019, 04:43 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Jun 27, 2019 | Sale | $3.45 | 1,458 | 5,025 | 813,434 | Jul 01, 2019, 04:35 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Jun 25, 2019 | Sale | $3.40 | 1,380 | 4,689 | 814,892 | Jun 27, 2019, 04:21 PM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Aug 29, 2018 | Sale | $0.45 | 29,999 | 13,521 | 5,731,117 | Aug 29, 2018, 05:22 PM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Aug 27, 2018 | Sale | $0.45 | 20,000 | 9,070 | 5,811,116 | Aug 29, 2018, 05:22 PM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Aug 28, 2018 | Sale | $0.45 | 50,000 | 22,597 | 5,791,116 | Aug 29, 2018, 05:22 PM | |
| ONTX | Onconova Therapeutics, Inc. | Bienen Henry S | Director | May 29, 2018 | Buy | $0.38 | 10,000 | 3,800 | 22,724 | May 31, 2018, 05:27 PM | |
| ONTX | Onconova Therapeutics, Inc. | 683 Capital Management, LLC | 10% Owner | Apr 27, 2018 | Buy | $0.43 | 11,838,235 | 5,031,250 | 14,503,169 | May 01, 2018, 05:14 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Apr 27, 2018 | Buy | $0.43 | 10,147,058 | 4,312,500 | 12,244,080 | May 01, 2018, 04:12 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Feb 08, 2018 | Buy | $1.01 | 1,100,000 | 1,111,000 | 2,097,022 | Feb 12, 2018, 07:12 PM | |
| ONTX | Onconova Therapeutics, Inc. | 683 Capital Management, LLC | 10% Owner | Feb 08, 2018 | Buy | $1.04 | 200,000 | 207,120 | 2,664,934 | Feb 12, 2018, 04:37 PM | |
| ONTX | Onconova Therapeutics, Inc. | Bienen Henry S | Director | Apr 26, 2017 | Buy | $2.10 | 3,810 | 8,001 | 12,724 | Apr 28, 2017, 03:12 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | Chief Financial Officer | Apr 26, 2017 | Buy | $2.10 | 1,429 | 3,001 | 5,155 | Apr 28, 2017, 03:11 PM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Apr 26, 2017 | Buy | $2.10 | 11,906 | 25,003 | 36,321 | Apr 28, 2017, 03:04 PM | |
| ONTX | Onconova Therapeutics, Inc. | Reddy E Premkumar | Director | Apr 26, 2017 | Buy | $2.10 | 119,048 | 250,001 | 385,832 | Apr 28, 2017, 03:03 PM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Apr 26, 2017 | Buy | $2.10 | 23,810 | 50,001 | 102,227 | Apr 28, 2017, 03:03 PM | |
| ONTX | Onconova Therapeutics, Inc. | TYNDALL CAPITAL PARTNERS L P | 10% Owner | Apr 21, 2017 | Option Exercise | $2.10 | 476,190 | 999,999 | 997,022 | Apr 24, 2017, 06:06 PM | |
| ONTX | Onconova Therapeutics, Inc. | Bienen Henry S | Director | Jul 29, 2016 | Option Exercise | $4.10 | 7,420 | 30,422 | 8,914 | Aug 10, 2016, 09:13 PM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Jul 29, 2016 | Option Exercise | $4.10 | 528,845 | 2,168,264 | 980,673 | Aug 10, 2016, 08:48 PM | |
| ONTX | Onconova Therapeutics, Inc. | GROOPMAN JEROME | Director | Jun 29, 2016 | Option Exercise | $5.20 | 10 | 52 | 10 | Aug 10, 2016, 08:39 PM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Aug 01, 2016 | Option Exercise | $4.10 | 24,405 | 100,060 | 24,415 | Aug 10, 2016, 08:32 PM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Jul 29, 2016 | Option Exercise | $4.10 | 50,765 | 208,136 | 78,417 | Aug 10, 2016, 08:30 PM | |
| ONTX | Onconova Therapeutics, Inc. | Guerin Mark Patrick | Chief Accounting Officer | Jul 29, 2016 | Option Exercise | $4.10 | 3,666 | 15,031 | 3,726 | Aug 10, 2016, 08:24 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | Chief Medical Officer | Jul 29, 2016 | Option Exercise | $4.10 | 6,276 | 25,732 | 6,376 | Aug 10, 2016, 08:23 PM | |
| ONTX | Onconova Therapeutics, Inc. | Reddy E Premkumar | Director | Jul 29, 2016 | Option Exercise | $4.10 | 133,000 | 545,300 | 266,784 | Aug 10, 2016, 08:21 PM | |
| ONTX | Onconova Therapeutics, Inc. | Fruchtman Steven M | Chief Medical Officer | Jun 24, 2016 | Option Exercise | $6.50 | 100 | 650 | 100 | Jun 30, 2016, 05:26 PM | |
| ONTX | Onconova Therapeutics, Inc. | Maniar Manoj | SVP - Product Development | Jun 30, 2016 | Option Exercise | $6.50 | 50 | 325 | 50 | Jun 30, 2016, 05:24 PM | |
| ONTX | Onconova Therapeutics, Inc. | MARINO JAMES J | Director | Jun 27, 2016 | Option Exercise | $5.20 | 10 | 52 | 10 | Jun 29, 2016, 09:08 PM | |
| ONTX | Onconova Therapeutics, Inc. | Reddy E Premkumar | Director | May 02, 2014 | Option Exercise | $1.33 | 27,084 | 36,022 | 1,337,838 | Feb 03, 2015, 05:47 PM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Jul 07, 2014 | Option Exercise | $2.67 | 18,754 | 50,073 | 18,754 | Jul 09, 2014, 05:20 PM | |
| ONTX | Onconova Therapeutics, Inc. | Michael & Jane Hoffman 2013 Descendants | 10% Owner | Feb 20, 2014 | Buy | $8.03 | 71,740 | 576,072 | 4,446,535 | Feb 24, 2014, 07:51 AM | |
| ONTX | Onconova Therapeutics, Inc. | Michael & Jane Hoffman 2013 Descendants | 10% Owner | Feb 21, 2014 | Buy | $8.91 | 71,740 | 639,203 | 4,518,275 | Feb 24, 2014, 07:51 AM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Feb 20, 2014 | Buy | $8.03 | 71,740 | 576,072 | 4,446,535 | Feb 24, 2014, 07:50 AM | |
| ONTX | Onconova Therapeutics, Inc. | Hoffman Michael B | Director | Feb 21, 2014 | Buy | $8.91 | 71,740 | 639,203 | 4,518,275 | Feb 24, 2014, 07:50 AM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Feb 07, 2013 | Sale | $15.02 | 13,543 | 203,416 | 276,500 | Feb 11, 2014, 08:33 PM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Feb 07, 2014 | Option Exercise | $6.00 | 13,543 | 81,258 | 290,043 | Feb 11, 2014, 08:33 PM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Feb 10, 2014 | Sale | $10.55 | 40,000 | 422,200 | 296,500 | Feb 11, 2014, 08:33 PM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Feb 03, 2014 | Option Exercise | $10.53 | 40,000 | 421,400 | 296,500 | Feb 03, 2014, 08:25 PM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Jan 30, 2014 | Option Exercise | $10.09 | 40,000 | 403,498 | 296,500 | Feb 03, 2014, 08:25 PM | |
| ONTX | Onconova Therapeutics, Inc. | Kumar Ramesh | President and CEO | Jan 31, 2014 | Option Exercise | $10.51 | 40,000 | 420,600 | 296,500 | Feb 03, 2014, 08:25 PM |
Menu